The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
The genomic landscape of core-binding factor acute myeloid leukemias
Open accessAbstract
Acute myeloid leukemia (AML) comprises a heterogeneous group of leukemias frequently defined by recurrent cytogenetic abnormalities, including rearrangements involving the core-binding factor (CBF) transcriptional complex. To better understand the genomic landscape of CBF-AMLs, we analyzed both pediatric (n = 87) and adult (n = 78) samples, including cases with RUNX1-RUNX1T1 (n = 85) or CBFB-MYH11 (n = 80) rearrangements, by whole-genome or whole-exome sequencing. In addition to known mutations in the Ras pathway, we identified recurrent stabilizing mutations in CCND2, suggesting a previously unappreciated cooperating pathway in CBF-AML. Outside of signaling alterations, RUNX1-RUNX1T1 and CBFB-MYH11 AMLs demonstrated remarkably different spectra of cooperating mutations, as RUNX1-RUNX1T1 cases harbored recurrent mutations in DHX15 and ZBTB7A, as well as an enrichment of mutations in epigenetic regulators, including ASXL2 and the cohesin complex. This detailed analysis provides insights into the pathogenesis and development of CBF-AML, while highlighting dramatic differences in the landscapes of cooperating mutations for these related AML subtypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,905
Self-citationCircular binary segmentation for the analysis of array-based DNA copy number data
Olshen, A. B., Venkatraman, E. S., Lucito, R., & Wigler, M. (2004) · Biostatistics · doi:10.1093/biostatistics/kxh008 · Cited by 2,325
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
Self-citationThe origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
Self-citationDeciphering Signatures of Mutational Processes Operative in Human Cancer
Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J., & Stratton, M. R. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.12.008 · Cited by 1,277
Mutations driving CLL and their evolution in progression and relapse
Landau, D. A., Tausch, E., Taylor-Weiner, A. N., Stewart, C., Reiter, J. G., Bahlo, J., Kluth, S., Bozic, I., Lawrence, M., Böttcher, S., et al. (2015) · Nature · doi:10.1038/nature15395 · Cited by 1,068
Self-citationAn oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Mansour, M. R., Abraham, B. J., Anders, L., Berezovskaya, A., Gutierrez, A., Durbin, A. D., Etchin, J., Lawton, L., Sallan, S. E., Silverman, L. B., et al. (2014) · Science · doi:10.1126/science.1259037 · Cited by 801
Demethylation of H3K27 Regulates Polycomb Recruitment and H2A Ubiquitination
Lee, M. G., Villa, R., Trojer, P., Norman, J., Yan, K.-P., Reinberg, D., Di Croce, L., & Shiekhattar, R. (2007) · Science · doi:10.1126/science.1149042 · Cited by 771
A novel retinoblastoma therapy from genomic and epigenetic analyses
Zhang, J., Benavente, C. A., McEvoy, J., Flores-Otero, J., Ding, L., Chen, X., Ulyanov, A., Wu, G., Wilson, M., Wang, J., et al. (2012) · Nature · doi:10.1038/nature10733 · Cited by 516
Self-citationDeardorff, M. A., Kaur, M., Yaeger, D., Rampuria, A., Korolev, S., Pie, J., Gil-Rodríguez, C., Arnedo, M., Loeys, B., Kline, A. D., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511888 · Cited by 510
Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
Bouchard, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5321 · Cited by 502
CREST maps somatic structural variation in cancer genomes with base-pair resolution
Wang, J., Mullighan, C. G., Easton, J., Roberts, S., Heatley, S. L., Ma, J., Rusch, M. C., Chen, K., Harris, C. C., Ding, L., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1628 · Cited by 496
Self-citationGene expression profiling of pediatric acute myelogenous leukemia
Ross, M. E., Mahfouz, R., Onciu, M., Liu, H.-C., Zhou, X., Song, G., Shurtleff, S. A., Pounds, S., Cheng, C., Ma, J., et al. (2004) · Blood · doi:10.1182/blood-2004-03-1154 · Cited by 448
Self-citationHiguchi, M., O'Brien, D., Kumaravelu, P., Lenny, N., Yeoh, E.-J., & Downing, J. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00016-8 · Cited by 440
Self-citationHu, D., Gao, X., Morgan, M. A., Herz, H.-M., Smith, E. R., & Shilatifard, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01181-13 · Cited by 439
Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C. J., Burel, S. A., Lagasse, E., Weissman, I. L., Akashi, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171321298 · Cited by 431
Papaemmanuil, E., Rapado, I., Li, Y., Potter, N. E., Wedge, D. C., Tubio, J., Alexandrov, L. B., Van Loo, P., Cooke, S. L., Marshall, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.2874 · Cited by 402
Self-citationHerz, H.-M., Mohan, M., Garruss, A. S., Liang, K., Takahashi, Y.-H., Mickey, K., Voets, O., Verrijzer, C. P., & Shilatifard, A. (2012) · Genes & Development · doi:10.1101/gad.201327.112 · Cited by 388
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms
Kon, A., Shih, L.-Y., Minamino, M., Sanada, M., Shiraishi, Y., Nagata, Y., Yoshida, K., Okuno, Y., Bando, M., Nakato, R., et al. (2013) · Nature Genetics · doi:10.1038/ng.2731 · Cited by 384
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
Huether, R., Dong, L., Chen, X., Wu, G., Parker, M., Wei, L., Ma, J., Edmonson, M. N., Hedlund, E. K., Rusch, M. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4630 · Cited by 379
Self-citationExome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Jiang, L., Gu, Z.-H., Yan, Z.-X., Zhao, X., Xie, Y.-Y., Zhang, Z.-G., Pan, C.-M., Hu, Y., Cai, C.-P., Dong, Y., et al. (2015) · Nature Genetics · doi:10.1038/ng.3358 · Cited by 366
Self-citationBoissel, N., Leroy, H., Brethon, B., Philippe, N., de Botton, S., Auvrignon, A., Raffoux, E., Leblanc, T., Thomas, X., Hermine, O., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404188 · Cited by 357
Care, R. S., Valk, P. J. M., Goodeve, A. C., Abu‐Duhier, F. M., Geertsma‐Kleinekoort, W. M. C., Wilson, G. A., Gari, M. A., Peake, I. R., Löwenberg, B., & Reilly, J. T. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04362.x · Cited by 323
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
Abdel-Wahab, O., Gao, J., Adli, M., Dey, A., Trimarchi, T., Chung, Y. R., Kuscu, C., Hricik, T., Ndiaye-Lobry, D., LaFave, L. M., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20131141 · Cited by 322
MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia
Chen, C., Liu, Y., Rappaport, A. R., Kitzing, T., Schultz, N., Zhao, Z., Shroff, A. S., Dickins, R. A., Vakoc, C. R., Bradner, J. E., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.016 · Cited by 311
Self-citationIntegrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
He, J., Abdel-Wahab, O., Nahas, M. K., Wang, K., Rampal, R. K., Intlekofer, A. M., Patel, J., Krivstov, A., Frampton, G. M., Young, L. E., et al. (2016) · Blood · doi:10.1182/blood-2015-08-664649 · Cited by 311
Self-citationImplications of NRAS mutations in AML: a study of 2502 patients
Bacher, U., Haferlach, T., Schoch, C., Kern, W., & Schnittger, S. (2006) · Blood · doi:10.1182/blood-2005-08-3522 · Cited by 303
Castilla, L. H., Garrett, L., Adya, N., Orlic, D., Dutra, A., Anderson, S., Owens, J., Eckhaus, M., Bodine, D., & Liu, P. P. (1999) · Nature Genetics · doi:10.1038/13776 · Cited by 302
Yan, M., Kanbe, E., Peterson, L. F., Boyapati, A., Miao, Y., Wang, Y., Chen, I.-M., Chen, Z., Rowley, J. D., Willman, C. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1443 · Cited by 279
Mouse models of human AML accurately predict chemotherapy response
Zuber, J., Radtke, I., Pardee, T. S., Zhao, Z., Rappaport, A. R., Luo, W., McCurrach, M. E., Yang, M.-M., Dolan, M. E., Kogan, S. C., et al. (2009) · Genes & Development · doi:10.1101/gad.1771409 · Cited by 279
Self-citationPrp43: An RNA helicase-like factor involved in spliceosome disassembly
Arenas, J. E., & Abelson, J. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.11798 · Cited by 252
Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons
Chao, J.-R., Parganas, E., Boyd, K., Hong, C. Y., Opferman, J. T., & Ihle, J. N. (2008) · Nature · doi:10.1038/nature06604 · Cited by 251
Self-citationComprehensive mutational profiling of core binding factor acute myeloid leukemia
Duployez, N., Marceau-Renaut, A., Boissel, N., Petit, A., Bucci, M., Geffroy, S., Lapillonne, H., Renneville, A., Ragu, C., Figeac, M., et al. (2016) · Blood · doi:10.1182/blood-2015-12-688705 · Cited by 250
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
Goemans, B. F., Zwaan, C. M., Miller, M., Zimmermann, M., Harlow, A., Meshinchi, S., Loonen, A. H., Hählen, K., Reinhardt, D., Creutzig, U., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403870 · Cited by 243
The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice
Schessl, C., Rawat, V. P. S., Cusan, M., Deshpande, A., Kohl, T. M., Rosten, P. M., Spiekermann, K., Humphries, R. K., Schnittger, S., Kern, W., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24225 · Cited by 237
Cai, X., Gao, L., Teng, L., Ge, J., Oo, Z. M., Kumar, A. R., Gilliland, D. G., Mason, P. J., Tan, K., & Speck, N. A. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.002 · Cited by 235
Downing, J. R. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01377.x · Cited by 211
Self-citationSystematical Optimization of Reverse-Phase Chromatography for Shotgun Proteomics
Xu, P., Duong, D. M., & Peng, J. (2009) · Journal of Proteome Research · doi:10.1021/pr900251d · Cited by 201
Edelmann, J., Holzmann, K., Miller, F., Winkler, D., Bühler, A., Zenz, T., Bullinger, L., Kühn, M. W. M., Gerhardinger, A., Bloehdorn, J., et al. (2012) · Blood · doi:10.1182/blood-2012-04-423517 · Cited by 196
Self-citationMartin, A., Schneider, S., & Schwer, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200762200 · Cited by 192
Paschka, P., Du, J., Schlenk, R. F., Gaidzik, V. I., Bullinger, L., Corbacioglu, A., Späth, D., Kayser, S., Schlegelberger, B., Krauter, J., et al. (2013) · Blood · doi:10.1182/blood-2012-05-431486 · Cited by 185
Self-citationHurlin, P. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.7019 · Cited by 184
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations
Inoue, D., Kitaura, J., Togami, K., Nishimura, K., Enomoto, Y., Uchida, T., Kagiyama, Y., Kawabata, K. C., Nakahara, F., Izawa, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70739 · Cited by 172
Farrar, J. E., Schuback, H. L., Ries, R. E., Wai, D., Hampton, O. A., Trevino, L. R., Alonzo, T. A., Guidry Auvil, J. M., Davidsen, T. M., Gesuwan, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1015 · Cited by 163
Dolnik, A., Engelmann, J. C., Scharfenberger‐Schmeer, M., Mauch, J. A., Kelkenberg-Schade, S., Haldemann, B., Fries, T., Krönke, J., Kühn, M. W. M., Paschka, P., et al. (2012) · Blood · doi:10.1182/blood-2011-12-401471 · Cited by 162
Self-citationMirzaa, G., Parry, D. A., Fry, A. E., Giamanco, K. A., Schwartzentruber, J., Vanstone, M. R., Logan, C. V., Roberts, N. Y., Johnson, C. A., Singh, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2948 · Cited by 153
Prp43p contains a processive helicase structural architecture with a specific regulatory domain
Walbott, H., Mouffok, S., Capeyrou, R., Lebaron, S., Humbert, O., TILBEURGH, H. V., Henry, Y. A. L., & Leulliot, N. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.102 · Cited by 151
Tie, F., Banerjee, R., Conrad, P. A., Scacheri, P. C., & Harte, P. J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06392-11 · Cited by 146
Micol, J., Duployez, N., Boissel, N., Petit, A., Geffroy, S., Nibourel, O., Lacombe, C., Lapillonne, H., Etancelin, P., Figeac, M., et al. (2014) · Blood · doi:10.1182/blood-2014-04-571018 · Cited by 130
Prp43p Is a DEAH-Box Spliceosome Disassembly Factor Essential for Ribosome Biogenesis
Combs, D. J., Nagel, R. J., Ares, M., & Stevens, S. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.523-534.2006 · Cited by 123
Bullinger, L., Rücker, F. G., Kurz, S., Du, J., Scholl, C., Sander, S., Corbacioglu, A., Lottaz, C., Krauter, J., Fröhling, S., et al. (2007) · Blood · doi:10.1182/blood-2006-10-049783 · Cited by 122
Self-citationChen, B. B., Glasser, J. R., Coon, T. A., Zou, C., Miller, H. L., Fenton, M. J., McDyer, J. F., Boyiadzis, M. M., & Mallampalli, R. K. (2012) · Blood · doi:10.1182/blood-2011-06-358911 · Cited by 107
Spliceosome discards intermediates via the DEAH box ATPase Prp43p
Mayas, R. M., Maita, H., Semlow, D. R., & Staley, J. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906022107 · Cited by 100
Cohesinopathies, gene expression, and chromatin organization
Bose, T., & Gerton, J. L. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200912129 · Cited by 95
Nanri, T., Matsuno, N., Kawakita, T., Suzushima, H., Kawano, F., Mitsuya, H., & Asou, N. (2005) · Leukemia · doi:10.1038/sj.leu.2403803 · Cited by 94
CONSERTING: integrating copy number analysis with structural variation detection
Chen, X., Gupta, P., Wang, J.-M., Nakitandwe, J., Roberts, K., Dalton, J., Parker, M., Patel, S. N., Holmfeldt, L., Payne, D., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3394 · Cited by 87
Self-citationKühn, M. W. M., Radtke, I., Bullinger, L., Goorha, S., Cheng, J., Edelmann, J., Gohlke, J., Su, X., Paschka, P., Pounds, S. B., et al. (2012) · Blood · doi:10.1182/blood-2011-09-380444 · Cited by 83
Self-citationLavallée, V., Lemieux, S., Boucher, G., Gendron, P., Boivin, I., Armstrong, R. N., Sauvageau, G., & Hébert, J. (2016) · Blood · doi:10.1182/blood-2016-03-703868 · Cited by 75
Kuchenbauer, F. C., Schnittger, S., Look, T., Gilliland, G. D., Tenen, D. G., Haferlach, T., Hiddemann, W., Buske, C., & Schoch, C. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06229.x · Cited by 64
ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation
Hartmann, L., Dutta, S., Opatz, S., Vosberg, S., Reiter, K., Leubolt, G., Metzeler, K. H., Herold, T., Bamopoulos, S. A., Bräundl, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11733 · Cited by 64
Sood, R. B., Hansen, N. F., Donovan, F. X., Carrington, B., Bucci, D. M., Maskeri, B., Young, A., Trivedi, N. S., Kohlschmidt, J., Stone, R. M., et al. (2015) · Leukemia · doi:10.1038/leu.2015.141 · Cited by 63
Zhou, J.-Y., Schepmoes, A., Zhang, X., Moore, R., Monroe, M. E., Lee, J. H., Camp, D., Smith, R. D., & Qian, W. (2010) · Journal of Proteome Research · doi:10.1021/pr100508p · Cited by 59
Kida, A., Kakihana, K., Kotani, S., Kurosu, T., & Miura, O. (2007) · Oncogene · doi:10.1038/sj.onc.1210490 · Cited by 55
Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16).
Valk, P. J. M., Bowen, D., Frew, M. E., Goodeve, A. C., Löwenberg, B., & Reilly, J. T. (2004) · PubMed · Cited by 55
Nanri, T., Matsuno, N., Kawakita, T., Mitsuya, H., & Asou, N. (2005) · Leukemia · doi:10.1038/sj.leu.2403889 · Cited by 27
Olsson, L., Zettermark, S., Biloglav, A., Castor, A., Behrendtz, M., Forestier, E., Paulsson, K. M., & Johansson, B. (2016) · British Journal of Haematology · doi:10.1111/bjh.14056 · Cited by 14
Cited by
The landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572
Self-citationBolouri, H., Farrar, J. E., Triche, T., Ries, R. E., Lim, E. L., Alonzo, T. A., Ma, Y., Moore, R., Mungall, A. J., Marra, M. A., et al. (2018) · Nature Medicine · doi:10.1038/nm.4439 · Cited by 848
Self-citationGenomics of Acute Myeloid Leukemia Diagnosis and Pathways
Bullinger, L., Döhner, K., & Döhner, H. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.2208 · Cited by 541
Self-citationClonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Quek, L., David, M. D., Kennedy, A., Metzner, M., Amatangelo, M., Shih, A., Stoilova, B., Quivoron, C., Heiblig, M., Willekens, C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0115-6 · Cited by 200
Subtype-specific regulatory network rewiring in acute myeloid leukemia
Assi, S. A., Imperato, M. R., Coleman, D. J. L., Pickin, A., Potluri, S., Ptasinska, A., Chin, P. S., Blair, H., Cauchy, P., James, S. R., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0270-1 · Cited by 179
Metadata
- Authors
- Faber, Z. J., Chen, X., Gedman, A. L., Boggs, K., Cheng, J., Ma, J., Radtke, I., Chao, J.-R., Walsh, M. P., Song, G., Andersson, A. K., Dang, J., Dong, L., Liu, Y., Huether, R., Cai, Z., Mulder, H., Wu, G., Edmonson, M., Rusch, M., Qu, C., Li, Y., Vadodaria, B., Wang, J., Hedlund, E., Cao, X., Yergeau, D., Nakitandwe, J., Pounds, S. B., Shurtleff, S., Fulton, R. S., Fulton, L. L., Easton, J., Parganas, E., Pui, C.-H., Rubnitz, J. E., Ding, L., Mardis, E. R., Wilson, R. K., Gruber, T. A., Mullighan, C. G., Schlenk, R. F., Paschka, P., Döhner, K., Döhner, H., Bullinger, L., Zhang, J., Klco, J. M., & Downing, J. R.
- Venue
- Nature Genetics
- Published
- 2016-10-31
- Volume
- 48
- Issue
- 12
- Pages
- 1551-1556
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2546297708
- Cited by
- 269
- References
- 76
- FWCI
- 19.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.